Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Recs

0
Player Avatar Hotpicks101 (29.34) Submitted: 12/14/2010 4:03:47 PM : Outperform Start Price: $9.70 ALNY Score: +0.76

Following port on this one. Has fallen quite a bit should bounce back nicely.

Featured Broker Partners


Advertisement